series-a
Stage
4
Investors
About
LenioBio develops ALiCE®, a cell-free eukaryotic protein expression platform that enables rapid production of complex proteins, including membrane proteins, by using eukaryotic translation machinery without living cells.
Explore LenioBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.